RCUS insider buying – Arcus Biosciences, Inc.
26 insider purchases since 2016 worth $580.9M by 7 different insiders. Last 12 months: 0 purchases, $0. Most recent filing: 2025-02-27.
Mid company Public float $566M (latest 10-K, SEC).
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 21 older purchases (before the 5-year window) are listed in the table below.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. 10% Owner | $574.8M 4× · 23,261,731 sh | 2021-01-31 2025-02-18 | – | 31,424,760 shares as of 2025-02-20 | Holds - never sold |
| ROSEN TERRY J CEO | $3.7M 10× · 268,566 sh | 2018-03-19 2025-02-27 | 4× · $2.0M last 2025-12-16 | 2,236,409 shares as of 2026-01-26 | Sold part |
| FALBERG KATHRYN E Director | $1.5M 5× · 115,000 sh | 2018-03-19 2021-03-31 | – | 176,406 shares as of 2026-06-12 | Holds - never sold |
| Jaen Juan C. CEO | $433,122 4× · 45,000 sh | 2018-08-09 2019-06-27 | 14× · $10.3M last 2026-07-09 | 1,200,799 shares as of 2026-07-13 | Sold part |
| KANEKO YASUNORI Director | $330,852 2× · 24,133 sh | 2021-04-23 2025-02-27 | – | 957,955 shares as of 2026-06-12 | Holds - never sold |
| Goeltz II Robert C. CFO | $107,850 1× · 5,000 sh | 2020-09-09 2020-09-09 | 8× · $1.1M last 2026-05-11 | 84,161 shares as of 2026-05-12 | Sold part |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 0 | – | – | 7 | $4.1M |
| 2025 | 3 | $15.4M | 3 | 15 | $9.8M |
| 2024 | 1 | $320.0M | 1 | 5 | $2.3M |
| 2023 | 1 | $19.5M | 1 | 7 | $2.4M |
| 2022 | 0 | – | – | 11 | $2.5M |
| 2021 | 3 | $221.0M | 3 | 12 | $5.0M |
| 2020 | 2 | $1.1M | 2 | 1 | $66,368 |
| 2019 | 7 | $1.2M | 3 | – | – |
| 2018 | 9 | $2.7M | 3 | – | – |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2025-02-27 | ROSEN TERRY J | CEO | 19,800 | $10.18 | $201,564 | +0.8% | SEC |
| 2025-02-27 | KANEKO YASUNORI | Director | 20,000 | $10.06 | $201,200 | +238.1% | SEC |
| 2025-02-20 | GILEAD SCIENCES, INC. | 10% Owner | 1,363,636 | $11.00 | $15.0M | +4.5% | SEC |
| 2024-01-31 | GILEAD SCIENCES, INC. | 10% Owner | 15,238,095 | $21.00 | $320.0M | +102.8% | SEC |
| 2023-06-30 | GILEAD SCIENCES, INC. | 10% Owner | 1,010,000 | $19.26 | $19.5M | +7.3% | SEC |
| 2021-04-26 | KANEKO YASUNORI | Director | 4,133 | $31.37 | $129,652 | +137.8% | SEC |
| 2021-04-02 | FALBERG KATHRYN E | Director | 20,000 | $28.35 | $567,000 | +24.4% | SEC |
| 2021-02-02 | GILEAD SCIENCES INC | 10% Owner | 5,650,000 | $39.00 | $220.3M | +68.4% | SEC |
| 2020-09-09 | Goeltz II Robert C. | CFO | 5,000 | $21.57 | $107,850 | SEC | |
| 2020-08-11 | ROSEN TERRY J | CEO | 43,705 | $22.86 | $999,212 | +1.4% | SEC |
| 2019-06-28 | Jaen Juan C. | CEO | 15,000 | $7.59 | $113,802 | +0.5% | SEC |
| 2019-06-14 | FALBERG KATHRYN E | Director | 12,935 | $8.52 | $110,206 | +18.7% | SEC |
| 2019-06-13 | FALBERG KATHRYN E | Director | 20,000 | $8.20 | $163,900 | +40.7% | SEC |
| 2019-06-11 | FALBERG KATHRYN E | Director | 32,065 | $8.07 | $258,799 | +187.4% | SEC |
| 2019-06-07 | ROSEN TERRY J | CEO | 21,738 | $7.93 | $172,430 | +0.7% | SEC |
| 2019-06-05 | ROSEN TERRY J | CEO | 41,540 | $7.91 | $328,401 | +1.4% | SEC |
| 2019-06-04 | Jaen Juan C. | CEO | 10,000 | $8.25 | $82,500 | +0.4% | SEC |
| 2018-11-15 | Jaen Juan C. | CEO | 10,000 | $11.80 | $118,000 | +0.4% | SEC |
| 2018-08-29 | ROSEN TERRY J | CEO | 18,607 | $15.07 | $280,431 | +0.5% | SEC |
| 2018-08-24 | ROSEN TERRY J | CEO | 9,289 | $13.45 | $124,950 | +0.2% | SEC |
| 2018-08-21 | ROSEN TERRY J | CEO | 8,891 | $13.24 | $117,710 | +0.2% | SEC |
| 2018-08-16 | ROSEN TERRY J | CEO | 28,401 | $12.64 | $359,099 | +0.7% | SEC |
| 2018-08-13 | ROSEN TERRY J | CEO | 9,929 | $11.87 | $117,847 | +0.3% | SEC |
| 2018-08-13 | Jaen Juan C. | CEO | 10,000 | $11.88 | $118,820 | +0.4% | SEC |
| 2018-03-19 | ROSEN TERRY J | CEO | 66,666 | $15.00 | $999,990 | +1.7% | SEC |
| 2018-03-19 | FALBERG KATHRYN E | Director | 30,000 | $15.00 | $450,000 | +59.4% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-24 | Azoy Alexander | Officer | 2,827 | $30.00 | $84,810 | Pre-planned (10b5-1) | SEC |
| 2026-07-13 | Jaen Juan C. | CEO | 68,569 | $29.63 | $2.0M | Pre-planned (10b5-1) | SEC |
| 2026-06-24 | Jaen Juan C. | CEO | 31,431 | $27.92 | $877,526 | Sale | SEC |
| 2026-06-01 | Azoy Alexander | Officer | 2,562 | $25.77 | $66,023 | Pre-planned (10b5-1) | SEC |
| 2026-05-12 | Goeltz II Robert C. | CFO | 7,763 | $25.63 | $198,966 | Pre-planned (10b5-1) | SEC |
| 2026-01-07 | Jaen Juan C. | CEO | 31,823 | $21.41 | $681,342 | Pre-planned (10b5-1) | SEC |
| 2026-01-02 | Goeltz II Robert C. | CFO | 6,552 | $23.38 | $153,186 | Sale | SEC |
| 2025-12-18 | Tang Carolyn C. | Officer | 14,468 | $22.01 | $318,467 | Pre-planned (10b5-1) | SEC |
| 2025-12-18 | ROSEN TERRY J | CEO | 54,691 | $22.01 | $1.2M | Pre-planned (10b5-1) | SEC |
| 2025-12-18 | Markus Richard | Officer | 9,546 | $22.01 | $210,125 | Pre-planned (10b5-1) | SEC |
| 2025-12-18 | Jaen Juan C. | CEO | 21,208 | $22.01 | $466,826 | Pre-planned (10b5-1) | SEC |
| 2025-12-18 | Goeltz II Robert C. | CFO | 12,662 | $22.01 | $278,713 | Pre-planned (10b5-1) | SEC |
| 2025-12-18 | Azoy Alexander | Officer | 8,832 | $22.13 | $195,443 | Pre-planned (10b5-1) | SEC |
| 2025-12-05 | Jaen Juan C. | CEO | 82,997 | $24.71 | $2.1M | Pre-planned (10b5-1) | SEC |
| 2025-11-26 | Goeltz II Robert C. | CFO | 5,000 | $25.00 | $125,000 | Pre-planned (10b5-1) | SEC |
Showing the latest 15 of 58 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free